Amphotericin B-induced dilated cardiomyopathy

Sarosi, 1990, Amphotericin B still the “gold standard” for antifungal therapy, Post Grad Med, 88, 151, 10.1080/00325481.1990.11716368 Sarosi, 1990, Amphotericin B still the “gold standard” for antifungal therapy, Post Grad Med, 88, 155 Sarosi, 1990, Amphotericin B still the “gold standard” for antifungal therapy, Post Grad Med, 88, 165 Sabra, 1990, Amphotericin B nephrotoxicity, Drug Safety, 5, 94, 10.2165/00002018-199005020-00003 Lin, 1990, Amphotericin B blunts erythropoietin response to anemia, J Infect Dis, 161, 348, 10.1093/infdis/161.2.348 Wright, 1981, Lethal pulmonary reaction associated with combined use of amphotericin B and leukocytic transfusion, NEJM, 304, 1185, 10.1056/NEJM198105143042001 Craven, 1985, Risk factors of ventricular fibrillation during rapid amphotericin B infusion, Antimicrob Agents Chemother, 27, 868, 10.1128/AAC.27.5.868 Chung, 1971, A reversible cardiac enlargement during treatment with amphotericin B and hydrocortisone, 103, 831 Crews, 1992, Stunned myocardium in toxic shock syndrome, Ann Intern Med, 117, 912, 10.7326/0003-4819-117-11-912 Zhu, 1992, Myocardial stunning after electroconvulsive therapy, Ann Intern Med, 117, 914, 10.7326/0003-4819-117-11-914 Tsiplenkova, 1986, Ultrastructural and histochemical observations in human and experimental alcoholic cardiomyopathy, J Am Coll Cardiol, 8, 22A, 10.1016/S0735-1097(86)80025-0 Cruz, 1992, Rapid intravenous infusion of amphotericin B: a pilot study, Am J Med, 93, 123, 10.1016/0002-9343(92)90040-I